Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk

Introduction. Metabolic conditions, including type 2 diabetes, have been related to hepatocellular carcinoma (HCC) risk. We have further analyzed the role of diabetes and antidiabetic treatments on HCC. Methods. Data derived from a hospital-based case-control study (Italy, 2005–2012) on 224 HCC pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Miele, Luca, Bosetti, Cristina, Turati, Federica, Rapaccini, Gianlodovico, Gasbarrini, Antonio, La Vecchia, Carlo, Boccia, Stefania, Grieco, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444581/
https://www.ncbi.nlm.nih.gov/pubmed/26074956
http://dx.doi.org/10.1155/2015/570356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444581/
https://www.ncbi.nlm.nih.gov/pubmed/26074956
http://dx.doi.org/10.1155/2015/570356

Ejemplares similares